Arif Khan1, Masood A Khan1, Fahad A Alhumaydhi2, Ameen S S Alwashmi2, Khaled S Allemailem2, Mohammed A Alsahli2, Faris A Alrumaihi2, Ahmad Almatroudi2, Mugahid A Mobark3,4, Ayman Mousa1,5. 1. Department of Basic Health Sciences, College of Applied Medical Sciences, Qassim University, Al-Qassim, Buraydah, Saudi Arabia. 2. Department of Medical Laboratories, College of Applied Medical Sciences, Qassim University, Al-Qassim, Buraydah, Saudi Arabia. 3. Department of Pharmacy Practice, College of Pharmacy, Qassim University, Al-Qassim, Buraydah, Saudi Arabia. 4. Department of Pathology, Faculty of Medicine, University of Kordofan, El-Obeid, Sudan. 5. Department of Histology and Cell Biology, Faculty of Medicine, Benha University, Benha, Egypt.
Abstract
PURPOSE: Diallyl sulfide (DAS), one of the organo-sulfur secondary metabolites in garlic, has been shown to inhibit the proliferation of cancer cells. The present study aimed to evaluate the mechanism of DAS in the prevention of benzo[a]pyrene (BaP)-induced lung cancer in a murine model. MATERIALS AND METHODS: The mice were exposed to 50 mg/kg of BaP twice a week for 4 weeks in order to induce lung carcinoma. Pretreatment of mice with DAS (100 mg/kg) was started 2 weeks before BaP exposure and further continued for 21 weeks. The effect of DAS and BaP was evaluated by studying various parameters in the serum and tissues of the treated or untreated BaP-exposed mice. RESULTS: The histopathological findings demonstrated that DAS prevented the progression of malignant lung cancer and metastasis in the liver. A significant drop was observed in BaP-induced tumor marker enzymes (ADA, AHH, γ-GT, LDH) in the serum of the mice treated with DAS. Moreover, DAS treatment resulted in the recovery of antioxidant enzymes, SOD and CAT, in BaP-exposed mice. The induction of apoptosis and the destruction of cellular ROS were detected in cancer cells from the mice pre-treated with DAS. The immunohistochemical analysis revealed the up-regulation of fatty acid synthase (FASN) in the lungs and liver tissues of BaP-exposed mice and the treatment with DAS inhibited FASN expression. CONCLUSION: The findings of the present study indicated that DAS-induced apoptosis is strongly associated with the downregulation of FASN in tumor tissues. To the best of our knowledge, this is the first study that describes the role of FASN in BaP-induced lung carcinogenesis.
PURPOSE: Diallyl sulfide (DAS), one of the organo-sulfur secondary metabolites in garlic, has been shown to inhibit the proliferation of cancer cells. The present study aimed to evaluate the mechanism of DAS in the prevention of benzo[a]pyrene (BaP)-induced lung cancer in a murine model. MATERIALS AND METHODS: The mice were exposed to 50 mg/kg of BaP twice a week for 4 weeks in order to induce lung carcinoma. Pretreatment of mice with DAS (100 mg/kg) was started 2 weeks before BaP exposure and further continued for 21 weeks. The effect of DAS and BaP was evaluated by studying various parameters in the serum and tissues of the treated or untreated BaP-exposed mice. RESULTS: The histopathological findings demonstrated that DAS prevented the progression of malignant lung cancer and metastasis in the liver. A significant drop was observed in BaP-induced tumor marker enzymes (ADA, AHH, γ-GT, LDH) in the serum of the mice treated with DAS. Moreover, DAS treatment resulted in the recovery of antioxidant enzymes, SOD and CAT, in BaP-exposed mice. The induction of apoptosis and the destruction of cellular ROS were detected in cancer cells from the mice pre-treated with DAS. The immunohistochemical analysis revealed the up-regulation of fatty acid synthase (FASN) in the lungs and liver tissues of BaP-exposed mice and the treatment with DAS inhibited FASN expression. CONCLUSION: The findings of the present study indicated that DAS-induced apoptosis is strongly associated with the downregulation of FASN in tumor tissues. To the best of our knowledge, this is the first study that describes the role of FASN in BaP-induced lung carcinogenesis.
Authors: P S S Rao; Narasimha M Midde; Duane D Miller; Subhash Chauhan; Anil Kumar; Santosh Kumar Journal: Curr Drug Metab Date: 2015 Impact factor: 3.731
Authors: Paul E Goss; Kathrin Strasser-Weippl; Brittany L Lee-Bychkovsky; Lei Fan; Junjie Li; Yanin Chavarri-Guerra; Pedro E R Liedke; C S Pramesh; Tanja Badovinac-Crnjevic; Yuri Sheikine; Zhu Chen; You-lin Qiao; Zhiming Shao; Yi-Long Wu; Daiming Fan; Louis W C Chow; Jun Wang; Qiong Zhang; Shiying Yu; Gordon Shen; Jie He; Arnie Purushotham; Richard Sullivan; Rajendra Badwe; Shripad D Banavali; Reena Nair; Lalit Kumar; Purvish Parikh; Somasundarum Subramanian; Pankaj Chaturvedi; Subramania Iyer; Surendra Srinivas Shastri; Raghunadhrao Digumarti; Enrique Soto-Perez-de-Celis; Dauren Adilbay; Vladimir Semiglazov; Sergey Orlov; Dilyara Kaidarova; Ilya Tsimafeyeu; Sergei Tatishchev; Kirill D Danishevskiy; Marc Hurlbert; Caroline Vail; Jessica St Louis; Arlene Chan Journal: Lancet Oncol Date: 2014-04 Impact factor: 41.316
Authors: Arif Khan; Mohammed A Alsahli; Mohammad A Aljasir; Hamzah Maswadeh; Mugahid A Mobark; Faizul Azam; Khaled S Allemailem; Faris Alrumaihi; Fahad A Alhumaydhi; Ahmad A Almatroudi; Naif AlSuhaymi; Masood A Khan Journal: J Inflamm Res Date: 2022-04-08
Authors: Arif Khan; Mohd Azam; Masood Alam Khan; Khaled S Allemailem; Faris Alrumaihi; Ahmad Almatroudi; Fahad A Alhumaydhi; Hafiz Iqtidar Ahmad; Masih Uzzaman Khan Journal: Infect Drug Resist Date: 2021-04-21 Impact factor: 4.003
Authors: Ayman M Mousa; Khaled E A Soliman; Fahad Alhumaydhi; Ahmad Almatroudi; Osamah Al Rugaie; Khaled S Allemailem; Faris Alrumaihi; Arif Khan; Mohamad Y Rezk; Mohammad Aljasir; Ameen S S Alwashmi; Faris F Aba Alkhayl; Aqel S Albutti; Hanan S Seleem Journal: J Inflamm Res Date: 2021-11-27
Authors: Faris Alrumaihi; Masood Alam Khan; Ali Yousif Babiker; Mohammed Alsaweed; Faizul Azam; Khaled S Allemailem; Ahmad A Almatroudi; Syed Rizwan Ahamad; Mahdi H Alsugoor; Khloud Nawaf Alharbi; Nahlah Makki Almansour; Arif Khan Journal: Molecules Date: 2022-03-28 Impact factor: 4.411